Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.


2-Day Conference: Inhaled Drug Delivery (London, United Kingdom – November 1-2, 2018) –


The “Inhaled Drug Delivery” conference has been added to’s offering.

Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning across the technologies.

This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.

There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.

Programme to include:

  • Modern respiratory medicines
  • Innovation in nebulized therapy
  • Current and future trends for DPI formulation
  • Opportunities of nanoformulations in the lung
  • The role of lung protease in delivery of inhaled biopharmaceuticals
  • Lung deposition software: Mimetikos preludium: a new pharma friendly aerosol drug deposition calculator
  • Could smart inhalers dramatically change the way that Asthma and COPD patients are treated?
  • Decoding FDA’s recent combination drug product guidance: Applications to DPIs, pMDIs, and nasal sprays
  • The UK regulatory future – the way forward after Brexit
  • Navigating human factors in device development
  • The 1nhaler and its two jobs
  • Opportunities and challenges in the design of high-performance unit-dose dry powder inhalers
  • Design characterization of breath actuation mechanisms
  • Digitally enabled inhalers

For more information about this conference visit

Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now


Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.